Evidence map›Paper›PMID 38770353›Full record

ReviewJGH open : an open access journal of gastroenterology and hepatology2024

Evolution, adaptation, and new applications of the FODMAP diet.

Leigh O'Brien, Arezina Kasti, Emma P Halmos, Caroline Tuck, Jane Varney

Abstract readReview
In one paragraph

Review in JGH open : an open access journal of gastroenterology and hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Innovative concepts in diet therapies in disorders of gut-brain interaction.JGH open : an open access journal of gastroenterology and hepatology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leigh O'BrienDepartment of Medicine University of Otago Christchurch New Zealand.ORCID https://orcid.org/0000-0002-0763-081X
Arezina KastiDepartment of Nutrition and Dietetics ATTIKON University General Hospital Athens Greece.ORCID https://orcid.org/0000-0001-7282-4939
Emma P HalmosDepartment of Gastroenterology Monash University and Alfred Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-6063-5118
Caroline TuckDepartment of Nursing and Allied Health Swinburne University Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-5343-7842
Jane VarneyDepartment of Gastroenterology Monash University and Alfred Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0001-7820-057X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The FODMAP diet has been a treatment of irritable bowel syndrome (IBS) for many years. Rigorous scientific evaluation and clinical application of the FODMAP diet have generated deep understanding regarding clinical efficacy, mechanisms of action, and potential adverse effects of this dietary approach. In turn, this knowledge has allowed fine-tuning of the diet to optimize treatment benefits and minimize risks, in the form of the traditional three-phase diet; the FODMAP-gentle approach, which is a less restrictive iteration; and a proposed FODMAP-modified, Mediterranean-style diet which endeavours to optimise both gastrointestinal symptoms and other health parameters. Furthermore, recognition that IBS-like symptoms feature in other conditions has seen the FODMAP diet tested in non-IBS populations, including in older adults with diarrhea and women with endometriosis. These areas represent new frontiers for the FODMAP diet and a space to watch as future research evaluates the validity of these novel clinical applications.

Indexed as

dietirritable bowel syndromeluminal gastroenterology

Identifiers

PMID38770353
PMCPMC11103764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.